Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-08-02Clinical Trial Update: Comparison Of Rituximab Versus Tositumomab and Iodine I 131 Tositumomab (BEXXAR® Therapeutic Regimen) For Patients With Relapsed Follicular Non-Hodgkins Lymphoma [Phase 3]
A Phase 3 trial comparing Rituximab to Tositumomab with I-131 Tositumomab in relapsed follicular lymphoma has completed and posted results i…
-
CLINICAL_TRIALS trial_result · 2010-07-30Clinical Trial Update: Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia [Phase 1, Phase 2]
Phase 1/2 trial evaluating donor natural killer cell infusion with Rituximab, Aldesleukin, and chemotherapy in relapsed non-Hodgkin lymphoma…
-
CLINICAL_TRIALS trial_result · 2010-07-29Clinical Trial Update: The Effect of Rituximab on Mobilization With AMD3100 (Plerixafor) Plus G-CSF in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) or Hodgkin Disease (HD) [Phase 2]
A Phase 2 trial evaluated the effect of Rituximab on stem cell mobilization when used with AMD3100 (plerixafor) and G-CSF in relapsed or ref…
-
CLINICAL_TRIALS trial_result · 2010-07-28Clinical Trial Update: Multicenter Cross Sectional Study of Primary Intestine Lymphoma
A multicenter cross-sectional study on primary intestinal lymphoma (a form of Non-Hodgkin lymphoma) has completed.
-
CLINICAL_TRIALS trial_result · 2010-07-27Clinical Trial Update: High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating high-dose chemotherapy with an allogeneic hematopoietic cell transplant for Non-Hodgkin lymphoma has com…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-07-22Clinical Trial Update: Clinical Study on SyB L-0501 in Patients With Indolent B-cell Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma [Phase 2]
The Phase 2 clinical study of SyB L-0501 in patients with indolent B-cell non-Hodgkin's lymphoma and mantle cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2010-07-14Clinical Trial Update: Mobilization of Stem Cells With Plerixafor, Chemotherapy and G-CSF in Multiple Myeloma or Non-Hodgkin's Lymphoma Patients [Phase 2]
Phase 2 trial evaluating stem cell mobilization using plerixafor in combination with chemotherapy and G-CSF in patients with multiple myelom…
-
CLINICAL_TRIALS trial_result · 2010-06-22Clinical Trial Update: Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin as 2nd Line Therapy for Non-Hodgkin's Lymphoma (NHL) [Phase 2]
Phase 2 clinical trial evaluating a combination of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin as second-line thera…
-
CLINICAL_TRIALS trial_result · 2010-06-22Clinical Trial Update: BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, or Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial of BL22 immunotoxin in patients with refractory chronic lymphocytic leukemia, prolymphocytic leukemia, and non-Hodgkin lymphom…
-
CLINICAL_TRIALS research · 2010-06-22Clinical Trial Update: High-dose Chemotherapy and Stem Cell Transplantation for Central Nervous System (CNS) Relapse of Aggressive Lymphomas [Phase 2]
This entry describes a Phase 2 clinical trial evaluating high-dose chemotherapy followed by stem cell transplantation for CNS relapse of agg…
-
CLINICAL_TRIALS trial_result · 2010-06-11Clinical Trial Update: Bleomycin in Treating Patients With Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating Bleomycin for Non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2010-06-11Clinical Trial Update: Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma [Phase 1]
This Phase 1 trial of gene therapy and chemotherapy in patients with advanced solid tumors and Non-Hodgkin lymphoma was terminated, with no …
-
CLINICAL_TRIALS withdrawal · 2010-06-11Clinical Trial Update: Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma [NA]
The clinical trial evaluating PET imaging with FDG-18 to predict response in newly diagnosed Non-Hodgkin lymphoma patients treated with ritu…
-
CLINICAL_TRIALS trial_result · 2010-06-10Clinical Trial Update: Cyclophosphamide W/or W/Out Rituximab and Peripheral Stem Cell Transplantation in Patients With Recurrent Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 trial evaluating cyclophosphamide with or without rituximab followed by peripheral stem cell transplantation in patients with recu…
-
CLINICAL_TRIALS trial_result · 2010-06-10Clinical Trial Update: Molecular Risk Assessment in Planning Treatment for Patients With Non-Hodgkin's Lymphoma [Phase 2]
This clinical trial update notes the completion of a Phase 2 study on using molecular risk assessment to guide treatment decisions for patie…
-
CLINICAL_TRIALS trial_result · 2010-05-20Clinical Trial Update: Phase I Study of the Proteosome Inhibitor CEP 18770 in Patients With Solid Tumours or Non-Hodgkin's Lymphomas [Phase 1]
A Phase I study of CEP-18770, a proteasome inhibitor, in patients with solid tumors and Non-Hodgkin lymphoma has been completed.
-
CLINICAL_TRIALS trial_result · 2010-05-06Clinical Trial Update: A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation [Phase 2]
Phase 2 study evaluating Lupron Depot to enhance immune function after bone marrow transplantation was terminated, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2010-05-05Clinical Trial Update: Study of Immune Response Modifier in the Treatment of Hematologic Malignancies [Phase 2]
Phase 2 trial of an immune response modifier in hematologic malignancies has terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2010-04-02Clinical Trial Update: Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors [Phase 2]
Phase 2 trial update evaluating Interleukin-11 plus filgrastim as a pre-transplant regimen for patients undergoing peripheral stem cell tran…
-
CLINICAL_TRIALS trial_result · 2010-03-11Clinical Trial Update: Predictive Value of the "Cytocapacity Test" Patients With Lymphoproliferative Diseases and High-dose Therapy [Phase 2, Phase 3]
A completed Phase 2/Phase 3 trial evaluated the predictive value of the Cytocapacity Test in patients with Hodgkin lymphoma, Non-Hodgkin lym…
-
FDA approval · 2010-02-26FDA Approved: TREANDA — Supplemental Application (Cephalon, LLC)
The FDA approved a supplemental application for TREANDA (bendamustine hydrochloride) from Cephalon, LLC, enabling revisions to its labeling …
-
CLINICAL_TRIALS trial_result · 2010-01-29Clinical Trial Update: Study of Dynavax's 1018 ISS, Following Rituxan in Patients With B-Cell Follicular Lymphoma [Phase 2]
Phase 2 trial update of Dynavax's CpG 1018 adjuvant (1018 ISS) used after Rituxan in patients with B-cell follicular lymphoma; the study sta…
-
CLINICAL_TRIALS trial_result · 2010-01-27Clinical Trial Update: Study to Evaluate the Efficacy of Rituximab in Combination With Low-dose Radiotherapy in Patients With Relapsed Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating rituximab in combination with low-dose radiotherapy for relapsed non-Hodgkin's lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2010-01-12Clinical Trial Update: A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Non-Hodgkin Lymphoma (NHL).
This clinical trial update reports on the toxicity and outcomes observed in patients with Non-Hodgkin lymphoma treated with high-dose chemot…
-
CLINICAL_TRIALS trial_result · 2010-01-07Clinical Trial Update: INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma. [Phase 2]
The Phase II trial of gemcitabine plus irinotecan for relapsed or refractory Non-Hodgkin lymphoma has completed.